{"transactions":[{"id":745415,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-09T23:40:20.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2938,"derivative":{"exercise_price":237,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":2938},"source":{"system":"sec-edgar","filing":"0002001011-26-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000098/edgardoc.xml","form_type":"4"}},{"id":745414,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T23:40:20.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":42622,"source":{"system":"sec-edgar","filing":"0002001011-26-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000098/edgardoc.xml","form_type":"4"}},{"id":779895,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":false,"shares":1575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":69.51,"expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":1575},"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779894,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-12","kind":"exercise","planned":true,"acquired":false,"shares":459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":1575,"derivative":{"exercise_price":69.51,"expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":459},"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779893,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-13","kind":"sale","planned":true,"acquired":false,"shares":1575,"price":223.5,"value":352012.5,"ownership":{"direct":true},"balance_after":41786,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779892,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":true,"shares":1575,"price":69.51,"value":109478.25,"ownership":{"direct":true},"balance_after":43361,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779891,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":459,"price":224,"value":102816.0,"ownership":{"direct":true},"balance_after":41786,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779890,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-12","kind":"exercise","planned":true,"acquired":true,"shares":459,"price":69.51,"value":31905.09,"ownership":{"direct":true},"balance_after":42245,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779889,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":116,"price":234.0853,"value":27153.8948,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $233.6800 to $234.2400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41786,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779888,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":105,"price":232.5704,"value":24419.892,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $232.2000 to $232.9300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41902,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779887,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":165,"price":231.8671,"value":38258.0715,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $231.1200 to $232.0700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42007,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779886,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":1,"price":229.87,"value":229.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":42172,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":779885,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T01:08:34.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":80,"price":227.3675,"value":18189.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $227.1550 to $227.5800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42173,"source":{"system":"sec-edgar","filing":"0002001011-26-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000049/edgardoc.xml","form_type":"4"}},{"id":821504,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:43:34.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":159,"price":204.2627,"value":32477.7693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.0050 to $204.5400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42253,"source":{"system":"sec-edgar","filing":"0002001011-26-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000038/primary_doc.xml","form_type":"4"}},{"id":821503,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:43:34.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":43,"price":202.9122,"value":8725.2246,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.8550 to $203.6550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42412,"source":{"system":"sec-edgar","filing":"0002001011-26-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000038/primary_doc.xml","form_type":"4"}},{"id":821502,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:43:34.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":79,"price":202.4223,"value":15991.3617,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.0750 to $202.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42455,"source":{"system":"sec-edgar","filing":"0002001011-26-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000038/primary_doc.xml","form_type":"4"}},{"id":821501,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:43:34.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":40,"price":201.235,"value":8049.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.0050 to $201.4650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42534,"source":{"system":"sec-edgar","filing":"0002001011-26-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000038/primary_doc.xml","form_type":"4"}},{"id":821500,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:43:34.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":146,"price":199.9749,"value":29196.3354,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.6900 to $200.3150. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42574,"source":{"system":"sec-edgar","filing":"0002001011-26-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000038/primary_doc.xml","form_type":"4"}},{"id":863369,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T02:04:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":42,"price":203.57,"value":8549.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":42720,"source":{"system":"sec-edgar","filing":"0002001011-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000018/edgardoc.xml","form_type":"4"}},{"id":863368,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T02:04:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":50,"price":202.5388,"value":10126.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.1500 to $202.8700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42762,"source":{"system":"sec-edgar","filing":"0002001011-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000018/edgardoc.xml","form_type":"4"}},{"id":863367,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T02:04:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":83,"price":201.6472,"value":16736.7176,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.2150 to $202.0500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42812,"source":{"system":"sec-edgar","filing":"0002001011-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000018/edgardoc.xml","form_type":"4"}},{"id":863366,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T02:04:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":41,"price":200.404,"value":8216.564,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $200.1050 to $200.8400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42895,"source":{"system":"sec-edgar","filing":"0002001011-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000018/edgardoc.xml","form_type":"4"}},{"id":863365,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T02:04:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":204,"price":199.6894,"value":40736.6376,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.4100 to $200.0550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42936,"source":{"system":"sec-edgar","filing":"0002001011-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000018/edgardoc.xml","form_type":"4"}},{"id":863364,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-05T02:04:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":47,"price":197.1397,"value":9265.5659,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.0650 to $197.2000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43140,"source":{"system":"sec-edgar","filing":"0002001011-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000018/edgardoc.xml","form_type":"4"}},{"id":920226,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T22:18:56.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":23,"price":197.195,"value":4535.485,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":43187,"source":{"system":"sec-edgar","filing":"0002001011-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000007/edgardoc.xml","form_type":"4"}},{"id":920225,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T22:18:56.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":381,"price":196.3634,"value":74814.4554,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.0100 to $196.8400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43210,"source":{"system":"sec-edgar","filing":"0002001011-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000007/edgardoc.xml","form_type":"4"}},{"id":920224,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T22:18:56.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":23,"price":195.605,"value":4498.915,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":43591,"source":{"system":"sec-edgar","filing":"0002001011-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000007/edgardoc.xml","form_type":"4"}},{"id":920223,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T22:18:56.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":1,"price":192.18,"value":192.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":43614,"source":{"system":"sec-edgar","filing":"0002001011-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000007/edgardoc.xml","form_type":"4"}},{"id":920222,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T22:18:56.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":39,"price":191,"value":7449.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":43615,"source":{"system":"sec-edgar","filing":"0002001011-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000007/edgardoc.xml","form_type":"4"}},{"id":948629,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:47:45.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":46,"price":192.395,"value":8850.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":43654,"source":{"system":"sec-edgar","filing":"0002001011-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000004/edgardoc.xml","form_type":"4"}},{"id":948628,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:47:45.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":207,"price":190.2703,"value":39385.9521,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $189.7800 to $190.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43700,"source":{"system":"sec-edgar","filing":"0002001011-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000004/edgardoc.xml","form_type":"4"}},{"id":948627,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:47:45.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":102,"price":188.9627,"value":19274.1954,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $188.6000 to $189.3900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43907,"source":{"system":"sec-edgar","filing":"0002001011-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000004/edgardoc.xml","form_type":"4"}},{"id":948626,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:47:45.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":91,"price":187.9536,"value":17103.7776,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $187.6150 to $188.5700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44009,"source":{"system":"sec-edgar","filing":"0002001011-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000004/edgardoc.xml","form_type":"4"}},{"id":948625,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:47:45.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":21,"price":186.59,"value":3918.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":44100,"source":{"system":"sec-edgar","filing":"0002001011-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101126000004/edgardoc.xml","form_type":"4"}},{"id":982620,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":30,"price":200.0153,"value":6000.459,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.2800 to $200.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44121,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":982619,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":23,"price":199.215,"value":4581.945,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $198.2800 to $199.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44151,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":982618,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":92,"price":197.7168,"value":18189.9456,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $197.2800 to $198.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44174,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":982617,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":4,"price":196.345,"value":785.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $196.2800 to $197.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44266,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":982616,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":47,"price":195.7987,"value":9202.5389,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $195.2800 to $196.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44270,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":982615,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":179,"price":194.7582,"value":34861.7178,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $194.2800 to $195.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44317,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":982614,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T22:08:21.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":92,"price":193.8577,"value":17834.9084,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $193.2800 to $194.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44496,"source":{"system":"sec-edgar","filing":"0002001011-25-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000113/edgardoc.xml","form_type":"4"}},{"id":1007390,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T22:22:00.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":127,"price":192.3781,"value":24432.0187,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $192.1200 to $192.9700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44588,"source":{"system":"sec-edgar","filing":"0002001011-25-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000096/edgardoc.xml","form_type":"4"}},{"id":1007389,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T22:22:00.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":207,"price":191.2494,"value":39588.6258,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $190.9400 to $191.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44715,"source":{"system":"sec-edgar","filing":"0002001011-25-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000096/edgardoc.xml","form_type":"4"}},{"id":1007388,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T22:22:00.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":49,"price":190.2579,"value":9322.6371,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $189.7800 to $190.5750. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44922,"source":{"system":"sec-edgar","filing":"0002001011-25-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000096/edgardoc.xml","form_type":"4"}},{"id":1007387,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T22:22:00.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":84,"price":188.9968,"value":15875.7312,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $188.7150 to $189.5250. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44971,"source":{"system":"sec-edgar","filing":"0002001011-25-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000096/edgardoc.xml","form_type":"4"}},{"id":1025650,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:45:27.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":92,"price":181.1838,"value":16668.9096,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $180.9350 to $181.4000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45055,"source":{"system":"sec-edgar","filing":"0002001011-25-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000093/edgardoc.xml","form_type":"4"}},{"id":1025649,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:45:27.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":155,"price":180.0098,"value":27901.519,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $179.4800 to $180.3100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45147,"source":{"system":"sec-edgar","filing":"0002001011-25-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000093/edgardoc.xml","form_type":"4"}},{"id":1025648,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:45:27.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":196,"price":178.4051,"value":34967.3996,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $177.8750 to $178.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45302,"source":{"system":"sec-edgar","filing":"0002001011-25-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000093/edgardoc.xml","form_type":"4"}},{"id":1025647,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:45:27.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":24,"price":177.6048,"value":4262.5152,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $176.6800 to $177.6450. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45498,"source":{"system":"sec-edgar","filing":"0002001011-25-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000093/edgardoc.xml","form_type":"4"}},{"id":1048704,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:47:34.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":85,"price":164.248,"value":13961.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $163.9900 to $164.5000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45522,"source":{"system":"sec-edgar","filing":"0002001011-25-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000068/edgardoc.xml","form_type":"4"}},{"id":1048703,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:47:34.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":115,"price":162.5188,"value":18689.662,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $162.3600 to $162.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45607,"source":{"system":"sec-edgar","filing":"0002001011-25-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000068/edgardoc.xml","form_type":"4"}},{"id":1048702,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:47:34.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":267,"price":161.5135,"value":43124.1045,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $161.0300 to $162.0200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":45722,"source":{"system":"sec-edgar","filing":"0002001011-25-000068","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000068/edgardoc.xml","form_type":"4"}},{"id":1075480,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T21:03:25.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":467,"price":131.8755,"value":61585.8585,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":45989,"source":{"system":"sec-edgar","filing":"0002001011-25-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000059/edgardoc.xml","form_type":"4"}},{"id":1088959,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T22:17:22.000Z","date":"2025-07-10","kind":"sale","planned":true,"acquired":false,"shares":934,"price":125,"value":116750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1."}],"balance_after":46456,"source":{"system":"sec-edgar","filing":"0002001011-25-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000053/edgardoc.xml","form_type":"4"}},{"id":1116954,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-10T23:21:10.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":5783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5783,"derivative":{"exercise_price":105.99,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":5783},"source":{"system":"sec-edgar","filing":"0002001011-25-000041","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000041/edgardoc.xml","form_type":"4"}},{"id":1116953,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-10T23:21:10.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":1209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":47390,"source":{"system":"sec-edgar","filing":"0002001011-25-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000041/edgardoc.xml","form_type":"4"}},{"id":1128399,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-03T00:05:50.000Z","date":"2025-01-17","kind":"exercise","planned":false,"acquired":false,"shares":2406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 2,754 shares, which vested in full on April 24, 2016, at an exercise price of $89.7500 per share."}],"balance_after":0,"derivative":{"exercise_price":52.3,"expiration_date":"2025-04-24","underlying":"Common Stock","underlying_shares":2406},"source":{"system":"sec-edgar","filing":"0002001011-25-000036","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000036/edgardoc.xml","form_type":"4"}},{"id":1128398,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T00:05:50.000Z","date":"2025-01-17","kind":"exercise","planned":false,"acquired":true,"shares":2406,"price":52.3,"value":125833.8,"ownership":{"direct":true},"balance_after":46181,"source":{"system":"sec-edgar","filing":"0002001011-25-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101125000036/edgardoc.xml","form_type":"4"}},{"id":1476312,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-19T01:26:49.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5444,"derivative":{"exercise_price":80.06,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5444},"source":{"system":"sec-edgar","filing":"0002001011-24-000058","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000058/edgardoc.xml","form_type":"4"}},{"id":1476311,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:26:49.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":43775,"source":{"system":"sec-edgar","filing":"0002001011-24-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000058/edgardoc.xml","form_type":"4"}},{"id":1535038,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-04-26T22:35:31.000Z","date":"2024-04-24","kind":"exercise","planned":false,"acquired":false,"shares":2893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Option was previously reported as a Grant of 3,312 shares, which vested in full on April 24, 2015, at an exercise price of $67.53 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer."}],"balance_after":0,"derivative":{"exercise_price":39.35,"expiration_date":"2024-06-04","underlying":"Common Stock","underlying_shares":2893},"source":{"system":"sec-edgar","filing":"0002001011-24-000048","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000048/edgardoc.xml","form_type":"4"}},{"id":1535037,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-26T22:35:31.000Z","date":"2024-04-24","kind":"exercise","planned":false,"acquired":true,"shares":2893,"price":39.35,"value":113839.55,"ownership":{"direct":true},"balance_after":42523,"source":{"system":"sec-edgar","filing":"0002001011-24-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000200101124000048/edgardoc.xml","form_type":"4"}},{"id":1857834,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-13T22:54:53.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":5461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":5461,"derivative":{"exercise_price":73.76,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":5461},"source":{"system":"sec-edgar","filing":"0000886163-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000041/edgardoc.xml","form_type":"4"}},{"id":1857833,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T22:54:53.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":1142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":39630,"source":{"system":"sec-edgar","filing":"0000886163-23-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000041/edgardoc.xml","form_type":"4"}},{"id":1887565,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-18T21:18:57.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":4444,"price":77.2009,"value":343080.7996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.20 to $77.24. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number reflected in Column 5 reconciles the total number of shares beneficially held following the transactions reported herein."}],"balance_after":38488,"source":{"system":"sec-edgar","filing":"0000899243-23-013275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323013275/doc4.xml","form_type":"4"}},{"id":1898652,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-05-10T23:15:17.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":false,"shares":6408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and will fully vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":18.82,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":6408},"source":{"system":"sec-edgar","filing":"0000899243-23-012541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323012541/doc4.xml","form_type":"4"}},{"id":1898651,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T23:15:17.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":589,"price":77.0974,"value":45410.3686,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.02 to $77.19. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42213,"source":{"system":"sec-edgar","filing":"0000899243-23-012541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323012541/doc4.xml","form_type":"4"}},{"id":1898650,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T23:15:17.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":5819,"price":76.511,"value":445217.509,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.965. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42802,"source":{"system":"sec-edgar","filing":"0000899243-23-012541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323012541/doc4.xml","form_type":"4"}},{"id":1898649,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T23:15:17.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":true,"shares":6408,"price":18.82,"value":120598.56,"ownership":{"direct":true},"balance_after":48621,"source":{"system":"sec-edgar","filing":"0000899243-23-012541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924323012541/doc4.xml","form_type":"4"}},{"id":2076335,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-27T23:31:46.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":6623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023."}],"balance_after":6623,"derivative":{"exercise_price":67.03,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":6623},"source":{"system":"sec-edgar","filing":"0000899243-22-039410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322039410/doc4.xml","form_type":"4"}},{"id":2234858,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-13T22:45:58.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4340,"derivative":{"exercise_price":79.29,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4340},"source":{"system":"sec-edgar","filing":"0000886163-22-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000080/edgardoc.xml","form_type":"4"}},{"id":2234857,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:45:58.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":1004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":42213,"source":{"system":"sec-edgar","filing":"0000886163-22-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000080/edgardoc.xml","form_type":"4"}},{"id":2366975,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-01T21:34:59.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":7335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":12.53,"expiration_date":"2022-05-31","underlying":"Common Stock","underlying_shares":7335},"source":{"system":"sec-edgar","filing":"0000886163-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000033/edgardoc.xml","form_type":"4"}},{"id":2366974,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T21:34:59.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":908,"price":102.62,"value":93178.96,"ownership":{"direct":true},"balance_after":41209,"source":{"system":"sec-edgar","filing":"0000886163-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000033/edgardoc.xml","form_type":"4"}},{"id":2366973,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T21:34:59.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":7335,"price":12.53,"value":91907.55,"ownership":{"direct":true},"balance_after":42117,"source":{"system":"sec-edgar","filing":"0000886163-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000033/edgardoc.xml","form_type":"4"}},{"id":2680006,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-08T01:24:29.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":3269,"derivative":{"exercise_price":115.39,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000886163-21-000090","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000090/edgardoc.xml","form_type":"4"}},{"id":2680005,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T01:24:29.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":34782,"source":{"system":"sec-edgar","filing":"0000886163-21-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000090/edgardoc.xml","form_type":"4"}},{"id":2715361,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-14T00:57:13.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":4835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":10.12,"expiration_date":"2012-06-01","underlying":"Common Stock","underlying_shares":4835},"source":{"system":"sec-edgar","filing":"0000886163-21-000071","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000071/edgardoc.xml","form_type":"4"}},{"id":2715360,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T00:57:13.000Z","date":"2021-05-11","kind":"tax_withholding","acquired":false,"shares":391,"price":128.56,"value":50266.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer in payment of the exercise price of options."}],"balance_after":34152,"source":{"system":"sec-edgar","filing":"0000886163-21-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000071/edgardoc.xml","form_type":"4"}},{"id":2715359,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T00:57:13.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":4835,"price":10.12,"value":48930.2,"ownership":{"direct":true},"balance_after":34543,"source":{"system":"sec-edgar","filing":"0000886163-21-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000071/edgardoc.xml","form_type":"4"}},{"id":2841097,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-02-23T22:18:21.000Z","date":"2021-02-22","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date."}],"balance_after":4835,"derivative":{"exercise_price":10.12,"expiration_date":"2012-06-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000886163-21-000045","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000045/edgardoc.xml","form_type":"4"}},{"id":2841096,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T22:18:21.000Z","date":"2021-02-22","kind":"exercise","acquired":true,"shares":2500,"price":10.12,"value":25300.0,"ownership":{"direct":true},"balance_after":29708,"source":{"system":"sec-edgar","filing":"0000886163-21-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000045/edgardoc.xml","form_type":"4"}},{"id":3080250,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-17T20:30:45.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023."}],"balance_after":40000,"derivative":{"exercise_price":0.3075,"expiration_date":"2027-07-15","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-20-017808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1223000/000121390020017808/ownership.xml","form_type":"4"}},{"id":3112439,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-12T22:33:53.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2468,"derivative":{"exercise_price":117.58,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":2468},"source":{"system":"sec-edgar","filing":"0000886163-20-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000076/edgardoc.xml","form_type":"4"}},{"id":3112438,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T22:33:53.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":27208,"source":{"system":"sec-edgar","filing":"0000886163-20-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000076/edgardoc.xml","form_type":"4"}},{"id":3427961,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-08-27T20:20:14.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":100000,"price":0.459,"value":45900.0,"ownership":{"direct":true},"balance_after":151761,"source":{"system":"sec-edgar","filing":"0001213900-19-016793","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1223000/000121390019016793/ownership.xml","form_type":"4"}},{"id":3497899,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-07T22:48:23.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4071,"derivative":{"exercise_price":113.59,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":4071},"source":{"system":"sec-edgar","filing":"0000886163-19-000105","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000105/edgardoc.xml","form_type":"4"}},{"id":3497898,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T22:48:23.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":26377,"source":{"system":"sec-edgar","filing":"0000886163-19-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000105/edgardoc.xml","form_type":"4"}},{"id":3528544,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-05-14T23:56:51.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in twelve successive equal monthly installments upon completion of each calendar month of service beginning 5/29/09."}],"balance_after":0,"derivative":{"exercise_price":17.88,"expiration_date":"2019-05-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000886163-19-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/edgardoc.xml","form_type":"4"}},{"id":3528543,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T23:56:51.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":2500,"price":112.92,"value":282300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.24 to $113.23, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25542,"source":{"system":"sec-edgar","filing":"0000886163-19-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/edgardoc.xml","form_type":"4"}},{"id":3528542,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T23:56:51.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":2500,"price":17.88,"value":44700.0,"ownership":{"direct":true},"balance_after":28042,"source":{"system":"sec-edgar","filing":"0000886163-19-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/edgardoc.xml","form_type":"4"}},{"id":3531436,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2019-05-11T00:35:10.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":17.94,"exercise_date":"2020-05-08","expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-029154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919119029154/doc4.xml","form_type":"4"}},{"id":3531435,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-11T00:35:10.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001209191-19-029154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919119029154/doc4.xml","form_type":"4"}},{"id":3671079,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T23:19:51.000Z","date":"2018-05-14","kind":"gift","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30049,"source":{"system":"sec-edgar","filing":"0000886163-19-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000029/edgardoc.xml","form_type":"5"}},{"id":3803127,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T22:24:39.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":2500,"price":275.044,"value":687610.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.12 to $277.03, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26142,"source":{"system":"sec-edgar","filing":"0000886163-18-000141","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000141/edgardoc.xml","form_type":"4"}},{"id":3876968,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T22:50:51.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":2500,"price":207.4797,"value":518699.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.06 to $208.68, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28642,"source":{"system":"sec-edgar","filing":"0000886163-18-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000102/edgardoc.xml","form_type":"4"}},{"id":3876964,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-03T22:42:09.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":195.91,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000886163-18-000097","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000097/edgardoc.xml","form_type":"4/A","original_submission_date":"2018-06-21"}},{"id":3886504,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-21T20:41:30.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":76.77,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000899243-18-017599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017599/doc4.xml","form_type":"4"}},{"id":3886503,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T20:41:30.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":31142,"source":{"system":"sec-edgar","filing":"0000899243-18-017599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017599/doc4.xml","form_type":"4"}},{"id":3936946,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":40267,"kind":"person","name":"KOZARICH JOHN W","position":1,"cik":"0001223000","reported_name":"KOZARICH JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-12T01:09:00.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 4 equal quarterly installments following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-029722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919118029722/doc4.xml","form_type":"4"}}],"next_cursor":"2018-05-12T01:09:00.000000Z,3936946"}